Kyverna Therapeutics, Inc.
Kyverna Therapeutics, Inc.（KYTX）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
kytx · 股价预测 · 4 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 4 位华尔街分析师
Buy
4 位分析师
共识
评级分布
12 个月目标价
High
$33.00
Consensus
$30.75
+308.4% upside
Low
$25.00
Median: $32.5 · Last Close: $7.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$30.75
308.4% upside
High Target
$33
338.2%
Low Target
$25
232.0%
Current Price
$7.53
as of today
Based on analyst price targets, the KYTX stock price prediction for the next 12 months ranges from $25 to $33. The consensus KYTX price forecast of $30.75 implies 308.4% upside from the current price of $7.53.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $7.15 | ↓ 5.00% |
1-day model range: $7.1–$7.21. Peak: $7.21 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -63.8% |
| 2029 | $2 | -69.2% |
| 2030 | $2 | -71.8% |
| 2031 | — | -73.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · KYTX · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-13 | JP Morgan | Maintains | Overweight→Overweight |
| 2026-04-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-16 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-12-04 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2025-10-30 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-10-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-10-08 | Wells Fargo | Maintains | Overweight→Overweight |
| 2025-08-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Kyverna Therapeutics, Inc. (KYTX) stock. Of the recent 19 rating actions, 1 were upgrades and 0 were downgrades. 4 analysts currently cover KYTX.
分析师推荐趋势
KYTX analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$13M
↓ 76.5% YoY
Revenue Next Year
$18M
↑ 40.3% YoY
EPS This Year
$-2.87
EPS Next Year
$-2.94
↑ 2.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast KYTX EPS of $-2.87 for the current fiscal year, based on estimates from 5 analysts. The KYTX revenue forecast is $13M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
KYTX 股价预测由两类独立数据源支撑：来自 4 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。KYTX 的共识目标价为 $30.75（+308.4% 上行空间），分析师共识为 Buy。
KYTX 的短期预测（明日）为 $7.15（-5.00%）。 KYTX 对 2027 年的股价预测均值为 $4。 KYTX 对 2030 年的预测区间为 $2–$2。
Kyverna Therapeutics, Inc. 在 NASDAQ 上市，代码 KYTX。KYTX 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
KYTX 预测 · 8 个问题根据 4 位华尔街分析师，KYTX 的 12 个月平均目标价为 $30.75，最高 $33.00、最低 $25.00。若有图表，中位目标价可在上方查看。相对当前价 $7.53，隐含约 +308.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.